Translating cGMP analogues into a treatment for retinitis pigmentosa

Bidragets beskrivning

Inherited retinal degenerations, such as retinitis pigmentosa, cause loss of vision already at young age, because there is no cure to these diseases. In this project, new medication is being developed for the treatment of retinitis pigmentosa. The project aims to generate pre-clinical data that supports translation of the new medications to clinical studies. The role of University of Eastern Finland in this European project is related to formulation of the new compounds in nanostructures to reach targeted and prolonged drug activity.
Visa mer

Startår

2021

Slutår

2024

Beviljade finansiering

Arto Urtti Orcid -palvelun logo
272 383 €

Finansiär

Finlands Akademi

Typ av finansiering

Kansainvälinen yhteisrahoitteinen ohjelma

Övriga uppgifter

Finansieringsbeslutets nummer

344718

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Biolääketieteet

Identifierade teman

eyes, eye diseases